|Year : 2018 | Volume
| Issue : 1 | Page : 84
Aged garlic and cancer: A systematic review
Maryam Miraghajani1, Nahid Rafie2, Hossein Hajianfar3, Bagher Larijani4, Leila Azadbakht5
1 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; The Early Life Research Unit, Division of Child Health, Obstetrics and Gynaecology, University of Nottingham, Nottingham, UK
2 Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3 Department of Nutrition, School of Nutrition and Food Sciences, Semnan University of Medical Sciences, Semnan; Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
4 Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
5 Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences; Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
|Date of Submission||04-Oct-2017|
|Date of Acceptance||22-May-2018|
|Date of Web Publication||17-Sep-2018|
Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran
Source of Support: None, Conflict of Interest: None
Cancer is one of the leading causes of morbidity and mortality worldwide, which increases health-care costs. It has been reported that some dietary components such as aged garlic, one of the garlic preparations with no strong odor and harsh irritating taste, exhibits anticancer effects. This review summarizes the potential beneficial effects of aged garlic on cancer incidences as well as prevention and improvement of factors related to malignancy. Electronic databases, including MEDLINE, Web of Science, the Cochrane Library, and Google Scholar were searched. All study designs which were focused on cancer incidence, or indices related to malignancy as outcomes in human, animal, and human cells studies, and aged garlic and its ingredients as exposures were reviewed in accordance to the items for systematic reviews (PRISMA) guidelines. Initially, 304 articles were identified. Then, 25 articles which met the inclusion criteria were selected. Based on the evaluation, overall quality score of human studies was well. Although there were inconsistent evidence from human studies, results of the animal and laboratory results were mostly consistent. The overall findings may suggest that intakes of aged garlic are inversely associated with cancer. In this regard, the studies have shortcomings. Therefore, more precise investigations will be necessary to decide whether aged garlic consumption is recommendable as a part of cancer prevention or control programs. However, due to anticancer properties of aged garlic, its consumption along with healthy diet may have beneficial effects on cancer.
Keywords: Aged garlic, cancer, diet, systematic review
|How to cite this article:|
Miraghajani M, Rafie N, Hajianfar H, Larijani B, Azadbakht L. Aged garlic and cancer: A systematic review. Int J Prev Med 2018;9:84
| Introduction|| |
Cancer is one of the leading causes of morbidity and mortality worldwide, which increases health-care costs. Multiple genetic and environmental risk factors have been mentioned for cancer. Among environmental factors, diet plays an important role. Approximately one-third of cancer cases might be prevented by dietary modification., There is increasing evidence that dietary patterns and dietary components such as foods and nutrients play major roles in reducing or inducing the risk of cancer.,,,,,,,
Assessing the relation between the intakes of some kinds of vegetables such as allium vegetables, especially garlic and the risk of cancer is interesting. Garlic (Allium sativam L.) is a traditional herbal food in cancer prevention and it is mostly recommended vegetable in the pyramid by the National Cancer Institute.,
Interest in the therapeutic efficacy of garlic has origins in antiquity. Ancient medical texts from Egypt, Greece, Rome, China, and India each prescribed medical applications for garlic. Evidence for the anticancer effects of raw garlic also shows that it may affect cancer cells by modulation of many pathways including alteration in carcinogen-metabolizing enzymes, cell cycle arrest, and induction of apoptotic cell death and suppression of oncogenic signal transduction pathways. However, along with raw garlic benefits come some adverse effects. In addition, some people are reluctant to ingest raw garlic due to its unpleasant odor and taste. Hence, in order to reduce these attributes without losing biological functions, many types of garlic preparations have been developed.
Aged garlic is one of the garlic preparations with no strong odor and harsh irritating taste that is resulting from aging of fresh garlic in aqueous ethanol for >10 months at room temperature. During the aging processes, the levels of beneficial compounds, such as pyruvate and S-allylcysteine (SAC), are increased. Another recently identified antioxidant compound of aged garlic that is not present in raw- or heat-treated garlic is N-alpha-(1-deoxy-D-fructos-1-yl)-L-arginine which its activity is comparable to ascorbic acid. Some studies have also reported that the antioxidant activity of phenolic compounds of aged garlic, significantly were higher than raw garlic. Furthermore, aged garlic contains a key component called S-allylmercaptocysteine (SAMC), a water-soluble sulfur compound with antioxidant property that only appears after the aging process, inhibits cell growth, and promotes apoptosis in several cancer cell lines. In addition, it is suitable and tolerable for long-term consumption because it has rare adverse effects such as irritating. Yet, there is no report on toxic symptoms and interactions with medications of aged garlic.
Recently, there is increasing evidence of anticancer activity of aged garlic against several cancer types in human studies.,,, Furthermore, most animal and laboratory evidence reported effectiveness of aged garlic and components derived from aged garlic on tumor markers reduction.,,,,,,,,,,,,,, However, some of them showed contradictory effects.
Based on our exploration of the scientific literature, the efficacy of aged garlic on malignancy has not been systematically evaluated. Hence, the objective of this systematic review was to organize the results of research articles which included cancer incidence or indices related to malignancy as outcome and aged garlic and its ingredients as exposures.
| Methods|| |
All the review process was performed according to the PRISMA criteria. We searched MEDLINE, ISI Web of Science, the Cochrane library, and Google Scholar to identify published articles up to May 2018 that evaluated the effects of aged garlic on cancer. The main search terms and format was (neoplasia) and (aged garlic). Language, publication status, type of intervention, and time restriction were not applied.
According to our inclusion criteria, we considered human, animal, and human cell studies with cancer incidence and increase or decrease of any cancer markers such as number and size of adenomas, survival time, cell proliferation, apoptosis, and immunological indices. The significant change for each study was extracted as summary measures. Those studies that met our inclusion criteria were chosen. When title/abstract was not clear for the judgment to include the study, full text was checked. Studies were excluded if they focused exclusively on garlic and garlic extract. The process of selecting papers started with a screening of the 304 literature title. Those papers related to garlic and garlic extract (116 papers) and aged garlic without addressing cancer (147 papers) were left out. Furthermore, 15 articles were excluded because their intervention assessed animal cell line. Ultimately, our review involved 25 studies (4 human, 6 animal, and 15 human cells studies), which met the aforementioned criteria [Figure 1]. Quality of each human study was evaluated according to Downs quality assessment and a score from 0 to 27 was given to each study. Higher scores reflected higher quality. Furthermore, SYRCLE's RoB tool, an adapted version of the Cochrane RoB tool, was used to assess animal studies methodological quality that contains 10 items to investigate sources of bias.
|Figure 1: Study flow diagram of the search process and inclusion of studies into the systematic review|
Click here to view
[Table 1], [Table 2], [Table 3] provides information includes target population, age, study design, types of aged garlic used, study duration, authors, years, country, and summary of the outcomes.
|Table 1: Characteristics of various human cells studies that evaluated the effects of aged garlic on cancer|
Click here to view
|Table 2: Characteristics of various animal studies that evaluated the effects of aged garlic on cancer|
Click here to view
|Table 3: Characteristics of various human studies that evaluated the effects of aged garlic on cancer|
Click here to view
| Results|| |
Considering the type of the studies, the results were as follows:
In 15 studies, researchers examined the effects of aged garlic on the induced cancer on human cells which are summarized in [Table 1]. The proliferation assay showed inhibitory effect of aged garlic extract (AGE) on colorectal carcinoma cells in a dose-dependent model. Findings from the mentioned study suggest that AGE suppressed invasion of some version of cancer cells and not all of them. Suppression of invasion might be associated with enhanced adhesion and inhibited the migration endothelial cells in the presence of AGE. Furthermore, tube formation for reorganization stage of angiogenesis on endothelial cells was assayed and suggested that AGE have inhibitory effect on vessel formation at high concentration of AGE compared with low concentration. Regarding the evaluation of the Sigounas et al., SAMC suppresses development and survive breast and prostate, hormone-responsive cancer cell lines. This study highlighted that the response and sensitivity are different between cell variations. Evaluation of the relevant literature supported the inhibitory effect that SAC exerted on proliferation and differentiation of human neuroblastoma cells on time- and dose-dependent manner. Another trial which was conducted by Hong et al., nonsmall cell lung cancer cell line with normal p53, tumor suppressor gene product, and lacking p53 gene treated with various concentration of diallyl sulfide (DAS), diallyl disulfide (DADS), and garlic extract. Analysis suggested that three treatment reduced expression of B-cell lymphoma 2 (Bcl-2) gene, and cell death modulators, in both cells. Furthermore, garlic extract had slightly inhibitory effect in decreasing proliferation and increasing apoptosis in wild and null type cells compare with DAS and DADS. In the fifth study, culture of 2 types of human colon cancer cell with SAMC and SAC was assessed. SAMC had arrested properties in cycle cell in both the cells; however, this effect was different in SAMC concentration and type of cell. Similar results were obtained about apoptosis and mediating enzymes apoptosis such as caspase-3-like activity and c-Jun N-terminal protein kinase (JNK1) activity. However, similar report about SAC did not record. Furthermore, both SAC and SAMC confirmed increase in glutathione (GSH). Based on Chu et al. study, many types of human cancer cells lines, with SAC and SAMC were treated. Although SAMC was more effective than SAC, both of them exerted a suppressing effect on colony-forming, developing, and invasion rate on prostate cancer cells. Similar about these data were demonstrated about ovarian, nasopharyngeal, and esophageal cancer cell lines. Other evidence addressed that SAMC induces apoptosis in gastric tumor cells by modulate the apoptotic protein expression. Furthermore, SAMC worked on inhibition of tumor growth in a concentration-dependent manner. Likewise, another study appeared apoptotic effect of SAMC on human gastric cancer cells in a dose-dependent manner. It was noted that this property related to handling apoptotic proteins and enzymes. Another same study emphasized SAMC effects on JNK and P38 apoptosis pathway. Furthermore, SAMC can induce the apoptosis of cancer cells by activating the transforming growth factor-beta and inhibiting mitogen-activated protein kinase signaling pathway in hepatocellular carcinoma and colon cancer cell line. Moreover, another water-soluble allyl sulfide isolated from AGE, S-benzyl-cysteine (SBC), could have a cytotoxic activity on human gastric cancer through different pathways such as inducing cell cycle arrest and apoptosis. In addition, another study demonstrated that garlic extract and its fractions provided properties against melanoma. Among garlic extract fraction, R100 fraction more effective than others in suppressing melanoma cell line. The inhibitory effect of SAMC was also investigated on three ovarian cancer cell lines, HO8910, HO8910PM, and SKOV3. SAMC effectively induced apoptosis in the HO8910 and SKOV3 ovarian cancer cells by increasing the activity of caspase-3 and inhibited cells proliferation. In addition, invasion by reduced the expression of the adhesion factor, integrin β1, and induced the expression of E-cadherin was suppressed. However, differences of mRNA levels of the apoptosis-related genes: Bcl-2-associated X protein (Bax), Bcl-2, caspase-3, and survivin, between the SAMC-treated ovarian cancer cell lines were not significant. Further analyses showed that overexpression of surviving, a member of the inhibitor of apoptosis family, is a factor responsible for differential responses of ovarian cancer cells to SAMC. Furthermore, the mice were inoculated subcutaneously with HO8910, SKOV3, and HO8910PM ovarian cancer cells. Then, they subjected to intragastric administration of 0.3 mg/g (body wt) of SAMC daily for 21 days. The result showed that SAMC reduced the volume of subcutaneous tumors derived from HO8910 and SKOV3 cells. Furthermore, inhibitory effects of SAMC against precancerous carcinogenesis in human lung cells (A549 cell line) were examined. A549 cells were either pretreated (PreTM) or concurrently treated (CoTM) with 1 μM benzo (a) pyrene (B [a] P) as a carcinogen and either 10 or 50 μM SAMC. The 50 μM PreTM group inhibited B (a) P-induced cell proliferation by approximately 100%. The 50 μM SAMC PreTM and CoTM inhibited the B (a) P-induced G2/M phase shift by 100% and 97%, respectively. Furthermore, the mechanisms involved in SAMC inhibition of B (a) P-induced carcinogenesis were suppression of cell proliferation, cell cycle regulation, attenuation of reactive oxygen species (ROS) formation, inhibition of DNA damage, increase of superoxide dismutase (SOD) activity, and inhibition of nuclear factor-kappa B (NF-κB) activity. In another study, biological properties of Allium sativum lectin 50 protein (ASL50) from aged A. sativum bulbs were investigated. ASL50 exhibited antiproliferative activity on oral carcinoma KB cells with an IC50 of 36 μg/ml after treatment for 48 h and induced the apoptosis of cancer cells by inducing 2.5-fold higher caspase enzyme activity, a family of protease enzymes playing essential roles in programmed cell death, than untreated cells.
Six animal studies about cancer and aged garlic were identified and included in this review. Data extraction of these studies is shown in [Table 2]. In one of them, AGE contained 0.1% SAC was administered in different dose during the promotion phase of carcinogenesis. The placental GSH S-transferase (GST-P) form, new protein marker for preneoplastic liver foci, and bromodeoxyuridine (BrdU)-labeling indices, proliferation rate marker, were evaluated. The areas and numbers of GST-P-positive foci and BrdU labeling index reduction following administration of AGE in a dose-dependent manner were significantly addressed. Another study emphasized that diet containing the equivalent of 4% AGE could decrease the number of tumors in the small intestine. Moreover, the number of aberrant crypt foci, the earliest changes seen in the colon leading to cancer, and monoclonal antibody MIB-5 labeling index, the tool for determining proliferating cells, were reduced in the AGE-treated group as compared to untreated group. Results of another research suggested that different types of garlic preparations had different pharmacological properties in tumor cells in mice. These results showed although 3-month-old garlic extract could reduce tumor size, fresh garlic might cause desirable anticancer effects compared with other types of processed garlic extracts because of highest content of bioactive components. In contrast to previous studies, one study showed that component derived from aged garlic, SAC, had not actions of cancer chemoprevention in rat mammary tumor. Another study had documented that AGE had synergistic effects with naltrexone as an opioid receptor antagonist on malignancy assessment markers such as inhibition of tumor growth and increment of survival times. There is also a report regarding the growth-inhibiting activity of AGE on fibrosarcoma cells implanted in mice. Overall, most animal studies demonstrated a protective effect of AGE in the incidence or growth of carcinogen-induced tumors or tumor biomarker.
A limited number of human cancer studies have been conducted with aged garlic. [Table 3] are summarized the details of these informations. In one trial, the participants with advanced liver cancer or advanced pancreatic cancer, or advanced colon cancer were allocated into two groups, AGE group and placebo group. Participants in AGE group consumed the daily dose of AGE twice a day. They have been followed for 12 and 24 weeks after the beginning of the trial. Although no significant changes were identified in indices of cell-mediated immunity and other markers after AGE administering compared with control group, there was particular difference in natural killer (NK) cell activity in AGE group, especially in patients with advanced cancer of the gastrointestinal system. These improvements of immunity function may help to survive. These results were based on a small sample of patients with different types of cancer. Hence, it would be better if trial were performed with just focusing on one kind of cancer. Moreover, adjustment for confounding factors such as chemotherapy, drugs, and diet was not performed in the mentioned study. In addition, patients in control group consumed garlic when they knew beneficial effects of garlic during completing consent form. Ultimately, it would be better if death due to cancer has been followed up in this investigation. Another trial showed that daily consumption of 2.4 mL AGE in 51 diagnosed patients as carrying colorectal adenomas could significantly inhibit the number and size of adenomas in the treatment group after 6 and 12 months. However, we should keep in mind that protective factors of colorectal adenoma such as folate and regular nonsteroidal anti-inflammatory drug using and risk factors such as smoking and alcohol drinking might have confounding role in the obtained results. Further to mentioned point, it also seems that assessment of reliable markers of genetic risk factors of colorectal cancer is necessary. In another trial in this field, researchers reported that supplementation with AGE had not considerably chemoprevention effects on the incidence of precancerous gastric lesions. Even longer follow-up provided the same results. The obtained result may be due to differences of geographic regions and genetic factors. In other hand, Helicobacter pylori infection is an independent risk factor of gastric cancer. Furthermore, the prevalence of H. pylori- seropositive in the county of this study was 67%. Therefore, it needs to investigate the association between aged garlic intake and incidence of gastric cancer in the countries with lower prevalence of H. pylori. Moreover, origin of H. pylori strains affects rates of gastric cancer, and it may reduce the effect of interventions such as AGE supplementation. It seems necessary to evaluate the H. pylori strains when diet intervention is assessed. Furthermore, variability reading of the histopathology may affect the power to detect the effects of intervention.
| Discussion|| |
To the best of our knowledge, this is the first systematic review that evaluates the effects of aged garlic on cancer incidence prevention and improvement of indices related to malignancy. The human evidence in relation with aged garlic is insufficient and we identified four studies, with mentioned strategies. Although well-designed studies, long length of follow-up, treatment compliance, large number of participants, and low number of lost participants are strengths of most of these human evidence, the lack of studies evaluating in this field may be explained by the fact that most of the patients with cancer are hospitalized and have severe side effects of cancer that it cause to limit the study duration. Furthermore, it is also possible that bias may be related to unintended exposure to aged garlic and/or its products among participants in the control group. It must be kept in mind that several confounding factors such as dietary and supplement intakes have not been taken into account in these papers. Furthermore, received anticancer treatments during the studies by patients may probably affect aged garlic intervention.
In relation to possible components that could modify the effects of aged garlic, especially in human trial, many factors might have essential roles. Based on one report, dietary habits in patients with cancer may have changed after the diagnosis of this disease. This behavior changes may influence on dietary interventions studies. Moreover, administrated forms of AGE such as garlic fluid or powder extract, garlic preparation process, daily dose, duration of the study, or active components contained in each intervention were different. In addition, cancer phases, cancer type, correct staging of cancer, and differential diagnoses are critical and these may affect the assessment of recurrences or later development of malignancy. Furthermore, there are many of garlic's variety in different geographical region which have different active substances and effects. According to critical roles and predictive values of some prognostic factors such as gene expression, tumor markers, and age factor on tumorigenesis, it seems to be important to examine simultaneously heterogeneity of gene and age with aged garlic intervention in the mentioned studies., Furthermore, for preventive purposes, nutrients with anticarcinogenic properties should be used an early stage of carcinogenesis. Therefore, daily, long-term, and early possible ingestion of anticancer foods are important in cancer prevention or relief symptom.
In contrast to human studies, the results of the animal and laboratory results were mostly consistent and only some of them showed contradictory results. Animal and laboratory studies had generally poor quality and their results were not in the same line with clinical trials, which limits their usefulness to human cancer treatment. Although these models have so far been fruitful in understanding the mechanism of aged garlic intervention on malignancy, these results are not applicable to humans because of their biological differences. Hence, these findings must be repeated and confirmed by human models.
Possible mechanisms of AGE action are related to its variety compounds. The major unique organosulfur compounds in aged garlic are water-soluble SAC and SAMC, which have potent antioxidant activity. The lipid-soluble organosulfur components include DAS, DADS, diallyl polysulfides, and others compounds such as allixin demonstrate antioxidant activity. According to the reports, in malignant cells, high level of oxidative stress reaction and reactive species are essential as signal transduction for high proliferation rate. Hence, in the field of treatment of cancer, regulation of oxidative stress is novel therapeutic approaches. Therefore, oil-soluble and water-soluble compounds of aged garlic that have scavenging activity for ROS can decrease some tumor markers. Furthermore, SAC component increases antioxidant enzymes such as GST activity that causes enhancement of detoxification of carcinogens and inhibition of both the formation and bioactivities of carcinogens. SAC also decreased mutagenicity and binding of carcinogens to DNA by reduced formation of DNA adducts, a piece of DNA covalently bonded to a cancer causing. Other study indicated that induced GSH by AGE can change the level of reactive oxygen and is able to protect cells from carcinogenesis by scavenging free radicals, which may reduce cancer development. Stimulating the expression of nuclear factor – E2-related factor 2 and inhibit prooxidant enzymes such as inducible nitric oxide synthase by AGE and its components also may have potential effects on prevention oxidative stress. AGE probably exerts its inhibitory effect on oxidative stress by suppressing the influx of some metal ions through chelating them. Furthermore, the mechanisms involved in SAMC inhibition of induced carcinogenesis are attenuation of ROS formation, inhibition of DNA damage, increase of SOD activity, and inhibition of NF-κB activity. Recently, researches have provided evidence that immune system has the great potential for the specific elimination of tumors. Moreover, AGE may be a natural and excellent adjuvant to excite the immune system and increased interleukin 1, 2, and 4 (IL-1, IL-2, and IL-4), gamma interferon cytokines, and NK cells activity to improve antitumor immunity., Fraction 4, a protein fraction isolated from AGE, is a very efficient immunopotentiator and enhanced the cytotoxicity through augmenting macrophage, stimulated the lymphokine (IL-2)-activated killer activity against tumor cells. AGE also can act as angiogenesis inhibitor, and it has been proposed as angiopreventive, the prevention of motility, proliferation, and tube formation of endothelial cells through the inhibition of angiogenesis and were thought to be potential as cancer inhibitor. Moreover, AGE affects regulator proteins that regulate cell death. Mechanism of apoptosis induced by AGE are regulated through p53, which regulates the cell cycle and functions as a tumor suppressor, or related to Bax/Bcl-2 or JNK1, that plays roles in the cellular apoptosis pathway., In addition, SAC and SAMC demonstrated potent inhibition of vascular endothelial growth and exerted suppressed effect of colony-forming, development, and invasion rate of cancer cells. Invasive phenomenon accompanies with increase mesenchymal and decrease epithelial markers, such as E-cadherin and γ-catenin. Both compounds could reduce mesenchymal markers, such as α-smooth muscle actin (α-SMA) and vimentin.,
Our findings must be interpreted in the context of possible weaknesses. First, because of the insufficient studies included, due to limited access to some databases, and the natures of the studies, the findings cannot be used to infer causality. Second, most survey, particularly human studies were performed in particular population, and these results cannot be attributed to other populations. Although the mean score quality for all human articles considered was high (78.6%), considering the risk of bias across studies such as publication bias, performance bias, reporting bias, and potential conflicts of interest are important. Therefore, more clinical trials and prospective cohort human studies with adequate sample size in at-risk participants and patients with cancer in developed and developing countries are needed. It seems that pilot test assessment of risk of bias tools using a small subset of studies that represent the range of risk of bias in the evidence base is necessary. As mentioned previously, although SYRCLE's RoB tool was used to assess animal studies quality and all these studies achieved the same score quality (30%), but all of laboratory studies have not been reported their limitations; they have provided a clear definition of the available standard protocols used in methods.
| Conclusions|| |
Overall, the current findings are not sufficient to assess the effects of aged garlic on cancer. However, due to anticancer properties of aged garlic, its consumption along with healthy diet may have beneficial effects on cancer. More clinical trials and prospective cohort human studies with adequate sample size are necessary.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
López-Gómez M, Malmierca E, de Górgolas M, Casado E. Cancer in developing countries: The next most preventable pandemic. The global problem of cancer. Crit Rev Oncol Hematol 2013;88:117-22.
Garcia-Closas M, Gunsoy NB, Chatterjee N. Combined associations of genetic and environmental risk factors: Implications for prevention of breast cancer. J Natl Cancer Inst 2014;106. pii: dju305.
Brennan SF, Cantwell MM, Cardwell CR, Velentzis LS, Woodside JV. Dietary patterns and breast cancer risk: A systematic review and meta-analysis. Am J Clin Nutr 2010;91:1294-302.
Rastegari F, Rafieian-Kopaei M. Antioxidant supplements and cancer. Immunopathol Persa 2016;2:e14.
Farsinejad-Marj M, Talebi S, Ghiyasvand R, Miraghajani M. Adherence to mediterranean diet and risk of breast cancer in premenopausal and postmenopausal women. Arch Iran Med 2015;18:786-92.
Jolfaie NR, Mirzaie S, Ghiasvand R, Askari G, Miraghajani M. The effect of glutamine intake on complications of colorectal and colon cancer treatment: A systematic review. J Res Med Sci 2015;20:910-8.
] [Full text]
Rafie N, Golpour Hamedani S, Ghiasvand R, Miraghajani M. Kefir and cancer: A systematic review of literatures. Arch Iran Med 2015;18:852-7.
Hajibabaei K. The role of antioxidants and pro-oxidants in the prevention and treatment of cancers. Ann Res Antioxid 2016;1:09.
Nasri H. Herbal drugs and new concepts on its use. J Prev Epidemiol 2016;1:01.
Afaghi V, Afaghi A, Seddighi A. Diet and brain tumor: An epidemiological study. Curr Topics Nutraceuticals Res 2010;8:65.
Khayyatzadeh SS, Maghsoudi Z, Foroughi M, Askari G, Ghiasvand R. Dietary intake of zinc, serum levels of zinc and risk of gastric cancer: A review of studies. Adv Biomed Res 2015;4:118.
] [Full text]
Hovsepyan O, Zare-Farashbandi F, Askari G. A survey on cancer-related nutritional information in Iranian popular magazines. J Educ Health Promot 2015;4:102.
Wang HC, Pao J, Lin SY, Sheen LY. Molecular mechanisms of garlic-derived allyl sulfides in the inhibition of skin cancer progression. Ann N
Y Acad Sci 2012;1271:44-52.
Rafieian-Kopaei M, Baradaran A, Rafieian M. Plants antioxidants: From laboratory to clinic. J Nephropathol 2013;2:152-3.
Rivlin RS. Historical perspective on the use of garlic. J Nutr 2001;131:951S-4S.
Karmakar S, Choudhury SR, Banik NL, Ray SK. Molecular mechanisms of anti-cancer action of garlic compounds in neuroblastoma. Anticancer Agents Med Chem 2011;11:398-407.
Banerjee SK, Mukherjee PK, Maulik SK. Garlic as an antioxidant: The good, the bad and the ugly. Phytother Res 2003;17:97-106.
Capasso A. Antioxidant action and therapeutic efficacy of Allium sativum
L. Molecules 2013;18:690-700.
Xiao J, Ching YP, Liong EC, Nanji AA, Fung ML, Tipoe GL, et al.
Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo
animal model. Eur J Nutr 2013;52:179-91.
Tanaka S, Haruma K, Yoshihara M, Kajiyama G, Kira K, Amagase H, et al.
Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr 2006;136:821S-6S.
Macan H, Uykimpang R, Alconcel M, Takasu J, Razon R, Amagase H, et al.
Aged garlic extract may be safe for patients on warfarin therapy. J Nutr 2006;136:793S-795S.
Ishikawa H, Saeki T, Otani T, Suzuki T, Shimozuma K, Nishino H, et al.
Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J Nutr 2006;136:816S-20S.
Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, et al.
Fifteen-year effects of Helicobacter pylori
, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012;104:488-92.
You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, et al.
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006;98:974-83.
Chu Q, Ling MT, Feng H, Cheung HW, Tsao SW, Wang X, et al.
A novel anticancer effect of garlic derivatives: Inhibition of cancer cell invasion through restoration of E-cadherin expression. Carcinogenesis 2006;27:2180-9.
Cohen LA, Zhao Z, Pittman B, Lubet R. S-allylcysteine, a garlic constituent, fails to inhibit N-methylnitrosourea-induced rat mammary tumorigenesis. Nutr Cancer 1999;35:58-63.
Hakimzadeh H, Ghazanfari T, Rahmati B, Naderimanesh H. Cytotoxic effect of garlic extract and its fractions on Sk-mel3 melanoma cell line. Immunopharmacol Immunotoxicol 2010;32:371-5.
Hong YS, Ham YA, Choi JH, Kim J. Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Exp Mol Med 2000;32:127-34.
Katsuki T, Hirata K, Ishikawa H, Matsuura N, Sumi S, Itoh H, et al.
Aged garlic extract has chemopreventative effects on 1,2-dimethylhydrazine-induced colon tumors in rats. J Nutr 2006;136:847S-51S.
Lee Y. Induction of apoptosis by S-allylmercapto-L-cysteine, a biotransformed garlic derivative, on a human gastric cancer cell line. Int J Mol Med 2008;21:765-70.
Matsuura N, Miyamae Y, Yamane K, Nagao Y, Hamada Y, Kawaguchi N, et al.
Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J Nutr 2006;136:842S-6S.
Shirin H, Pinto JT, Kawabata Y, Soh JW, Delohery T, Moss SF, et al.
Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. Cancer Res 2001;61:725-31.
Shirzad H, Taji F, Rafieian-Kopaei M. Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice. J Med Food 2011;14:969-74.
Sigounas G, Hooker J, Anagnostou A, Steiner M. S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. Nutr Cancer 1997;27:186-91.
Uda N, Kashimoto N, Sumioka I, Kyo E, Sumi S, Fukushima S, et al.
Aged garlic extract inhibits development of putative preneoplastic lesions in rat hepatocarcinogenesis. J Nutr 2006;136:855S-60S.
Welch C, Wuarin L, Sidell N. Antiproliferative effect of the garlic compound S-allyl cysteine on human neuroblastoma cells in vitro
. Cancer Lett 1992;63:211-9.
Kumar S, Jitendra K, Singh K, Kapoor V, Sinha M, Xess I, et al.
Biological properties and characterization of ASL50 protein from aged Allium sativum
bulbs. Appl Biochem Biotechnol 2015;176:1914-27.
Wang K, Wang Y, Qi Q, Zhang F, Zhang Y, Zhu X, et al.
Inhibitory effects of S-allylmercaptocysteine against benzo(a) pyrene-induced precancerous carcinogenesis in human lung cells. Int Immunopharmacol 2016;34:37-43.
Wu J, Zhao S, Zhang J, Qu X, Jiang S, Zhong Z, et al.
Over-expression of survivin is a factor responsible for differential responses of ovarian cancer cells to S-allylmercaptocysteine (SAMC). Exp Mol Pathol 2016;100:294-302.
Krassioukov A, Eng JJ, Warburton DE, Teasell R; Spinal Cord Injury Rehabilitation Evidence Research Team. A systematic review of the management of orthostatic hypotension after spinal cord injury. Arch Phys Med Rehabil 2009;90:876-85.
Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW, et al.
SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol 2014;14:43.
Lee Y, Kim H, Lee J, Kim K. Anticancer activity of S-allylmercapto-L-cysteine on implanted tumor of human gastric cancer cell. Biol Pharm Bull 2011;34:677-81.
Yan JY, Tian FM, Hu WN, Zhang JH, Cai HF, Li N, et al.
Apoptosis of human gastric cancer cells line SGC 7901 induced by garlic-derived compound S-allylmercaptocysteine (SAMC). Eur Rev Med Pharmacol Sci 2013;17:745-51.
Tong D, Qu H, Meng X, Jiang Y, Liu D, Ye S, et al.
S-allylmercaptocysteine promotes MAPK inhibitor-induced apoptosis by activating the TGF-β signaling pathway in cancer cells. Oncol Rep 2014;32:1124-32.
Sun HJ, Meng LY, Shen Y, Zhu YZ, Liu HR. S-benzyl-cysteine-mediated cell cycle arrest and apoptosis involving activation of mitochondrial-dependent caspase cascade through the p53 pathway in human gastric cancer SGC-7901 cells. Asian Pac J Cancer Prev 2013;14:6379-84.
Ebrahimpour S, Tabari MA, Youssefi MR, Aghajanzadeh H, Behzadi MY. Synergistic effect of aged garlic extract and naltrexone on improving immune responses to experimentally induced fibrosarcoma tumor in BALB/c mice. Pharmacognosy Res 2013;5:189-94.
Fallah-Rostami F, Tabari MA, Esfandiari B, Aghajanzadeh H, Behzadi MY. Immunomodulatory activity of aged garlic extract against implanted fibrosarcoma tumor in mice. N Am J Med Sci 2013;5:207-12.
Hermann S, Rohrmann S, Linseisen J. Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-heidelberg. Cancer Causes Control 2009;20:1397-408.
Edwards TL, Shrubsole MJ, Cai Q, Li G, Dai Q, Rex DK, et al.
Genome-wide association study identifies possible genetic risk factors for colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2013;22:1219-26.
Guo DL, Dong M, Wang L, Sun LP, Yuan Y. Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori
-associated gastric diseases. World J Gastroenterol 2002;8:1009-13.
de Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, Chaturvedi R, et al.
Phylogeographic origin of Helicobacter pylori
is a determinant of gastric cancer risk. Gut 2011;60:1189-95.
Salminen EK, Lagström HK, Heikkilä S, Salminen S. Does breast cancer change patients' dietary habits? Eur J Clin Nutr 2000;54:844-8.
Sterling SJ, Eagling DR, editors. Agronomics and allicin yield of Australian grown garlic (Allium sativum
). II International Symposium on Edible Alliaceae. 1997. p.63-73.
Loffeld RJ, Dekkers PE, Flens M. The incidence of colorectal cancer is decreasing in the older age cohorts in the zaanstreek region in the Netherlands: An age-cohort effect. ISRN Gastroenterol 2013;2013:871308.
Yang Y, Xie Y, Xian L. Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: A system review and meta-analysis. J Exp Clin Cancer Res 2013;32:15.
Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, Lleonart ME, et al.
Oxidative stress and cancer: An overview. Ageing Res Rev 2013;12:376-90.
Colín-González AL, Santana RA, Silva-Islas CA, Chánez-Cárdenas ME, Santamaría A, Maldonado PD, et al.
The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection. Oxid Med Cell Longev 2012;2012:907162.
Liu Y, Zeng G. Cancer and innate immune system interactions: Translational potentials for cancer immunotherapy. J Immunother 2012;35:299-308.
Larypoor M, Bayat M, Zuhair MH, Akhavan Sepahy A, Amanlou M. Evaluation of the number of CD4(+) CD25(+) foxP3(+) treg cells in normal mice exposed to AFB1 and treated with aged garlic extract. Cell J 2013;15:37-44.
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||A randomized, double-blind, placebo-controlled crossover clinical trial to evaluate the anti-diabetic effects of Allium hookeri extract in the subjects with prediabetes
| ||Soo-Hyun Park,Ui-Jin Bae,Eun-Kyung Choi,Su-Jin Jung,Sung-Hyen Lee,Jae-Heon Yang,You-Suk Kim,Do-Youn Jeong,Hyun-Ju Kim,Byung-Hyun Park,Soo-Wan Chae |
| ||BMC Complementary Medicine and Therapies. 2020; 20(1) |
|[Pubmed] | [DOI]|
||Phytochemicals of garlic: Promising candidates for cancer therapy
| ||Yan Zhang,Xingping Liu,Jun Ruan,Xuan Zhuang,Xinzong Zhang,Zhiming Li |
| ||Biomedicine & Pharmacotherapy. 2020; 123: 109730 |
|[Pubmed] | [DOI]|
||Allium vegetables for possible future of cancer treatment
| ||Yahya Asemani,Nasrindokht Zamani,Maryam Bayat,Zahra Amirghofran |
| ||Phytotherapy Research. 2019; |
|[Pubmed] | [DOI]|